Zhitong Finance App News, Baiyunshan (00874.HK) announced that on November 9, 2026, the board of directors approved a matter for Guangzhou Pharmaceutical (a subsidiary of the company) to introduce strategic investors and implement targeted stock issuance through public listing on the Guangzhou Property Exchange. The capital increase and share expansion plan will attract no more than 15 investors, the issue price will not be less than RMB 3.46 per share, and the targeted issuance of no more than 1,734 billion shares will be issued. The estimated amount raised will not exceed RMB 6 billion.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.